Evidence map›Paper›PMID 29511548›Full record

ReviewUnited European gastroenterology journal2018

Citrulline as a marker of intestinal function and absorption in clinical settings: A systematic review and meta-analysis.

Konstantinos C Fragkos, Alastair Forbes

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in United European gastroenterology journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05590117 (The Possible Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer), which is not on this map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05590117 early_phase1unknown statusnot on this mapstarted 2022, after this paper: background citation

The Possible Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer

TypeinterventionalSponsorTanta UniversityRan2022 to 2024Enrolled48ConditionsColo-rectal Cancer, Neuropathy, Peripheral, MucositisArmsPentoxifylline, Placebo, FOLFOX-6 regimen
3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it, 181 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. [Decreased plasma citrulline is a biochemical marker in newborn screening forZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  16. Article
  17. Article
  18. Review
  19. Recent advances in the diagnosis of celiac disease.World journal of gastroenterology · 2025
    Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Konstantinos C Fragkos1University College London Hospitals, GI Services, London, UK.ORCID 0000-0002-7677-7989
Alastair ForbesUniversity of East Anglia, Norwich and Norfolk Medical School, Norwich, UK.
University College Hospital · GBUniversity of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCitrulline has been described as a marker of intestinal function or absorption but evidence varies according to clinical settings.

objectiveThe objective of this article is to examine the evidence of plasma citrulline as a marker of intestinal function and absorption in various clinical settings.

methodsStudies were examined for

resultsCitrulline levels are correlated strongly with small bowel length in short bowel syndrome patients (

conclusionThese findings allow us to advocate quite reasonably that citrulline is a marker of acute and chronic intestinal insufficiency.

Indexed as

Citrullineenteropathymeta-analysisshort bowel syndromesystematic review

Identifiers

PMID29511548
PMCPMC5833233
OpenAlexW2761612793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.